NextRNA Therapeutics Revenue

Biotechnology Research • Boston, Massachusetts, United States • 21-50 Employees

NextRNA Therapeutics revenue & valuation

Annual revenue	$4,300,000
Revenue per employee	$205,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$13,800,000
Total funding	$46,800,000

Key Contacts at NextRNA Therapeutics

Dominique Verhelle

Co-Founder, President And Ceo

Simarjot Singh Pabla

Associate Director, Computational Biology

Franz Gruswitz

Sr. Director, Rna And Protein Sciences

Sean Buchanan

Director

Jed Thompson

Associate Director - Biochemistry

Ahmed M. Said

Associate Director, Chemistry

Polina Freitas

Associate Director Of Operations

Company overview

Headquarters	40 Guest St, Boston, Massachusetts 02135, US
Phone number	+16175457707
Websites	nextrnatx.com nextrna.com
NAICS	541714
Founded	2020
Employees	21-50
Socials

NextRNA Therapeutics Email Formats

NextRNA Therapeutics uses 1 email format. The most common is {first initial} (e.g., j@nextrnatx.com), used 100% of the time.

Format	Example	Percentage
{first initial}	j@nextrnatx.com	100%

About NextRNA Therapeutics

NextRNA Therapeutics, Inc. is a Boston-based biotechnology company leading the next revolution of RNA-directed therapeutics. Our focus is on identifying and drugging long non-coding RNAs (lncRNAs) with small molecules in oncology and neuroscience. Our proprietary computational engine, combined with deep lncRNA biology expertise and strong drug discovery capabilities, positions us well to unlock the therapeutic value of lncRNAs, a vast and promising target space. NextRNA has assembled an experienced team of industry leaders, biology and chemistry experts, and drug developers, all driven by a common passion for working together and having an impact on science and patients.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Senior

Director

C-Suite

Employees by Department

NextRNA Therapeutics has 10 employees across 8 departments.

Departments

Number of employees

Funding Data

Explore NextRNA Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2022-04-01	4	$46,800,000

Funding Insights

$46,800,000

Total funding amount

$46,800,000

Most recent funding amount

Number of funding rounds

NextRNA Therapeutics Tech Stack

Discover the technologies and tools that power NextRNA Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Modernizr

JavaScript libraries

MediaElement.js

Video players

Animate.css

UI frameworks

Microsoft 365

jQuery Migrate

JavaScript libraries

Cloudflare

CDN

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

PHP

Programming languages

WordPress

Blogs

Unpkg

CDN

Splide

JavaScript libraries

Frequently asked questions

NextRNA Therapeutics is located in Boston, Massachusetts, US.

You can reach NextRNA Therapeutics at +16175457707.

NextRNA Therapeutics generates an estimated annual revenue of $4,300,000. This revenue figure reflects the company's market position and business performance in its industry.

NextRNA Therapeutics has an estimated valuation of $13,800,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

NextRNA Therapeutics was founded in 2020, making it 6 years old. The company has established itself as a significant player in its industry over this time.

NextRNA Therapeutics has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

NextRNA Therapeutics has raised a total of $46,800,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at NextRNA Therapeutics

Dominique Verhelle

Co-Founder, President And Ceo

Simarjot Singh Pabla

Associate Director, Computational Biology

Franz Gruswitz

Sr. Director, Rna And Protein Sciences

Sean Buchanan

Director

Jed Thompson

Associate Director - Biochemistry

Ahmed M. Said